C32H47F5O3S
606.8 g/mol
Ingrediente ativo (API)Perigo
Fulvestrant
Fulvestranto
CAS129453-61-8EC642-998-6
Categoria
Ingrediente ativo (API)
Classe do Composto
Esteroide
Uso Principal
Matéria-prima farmacêutica
Fulvestrant is a steroidal compound derived from 17beta-estradiol, modified with a nonyl group and a pentafluoropentylsulfinyl substituent. It functions as an estrogen receptor antagonist and is used in pharmaceutical manufacturing as an active pharmaceutical ingredient.
Pharmaceutical raw material for hormone-sensitive breast cancer therapiesEstrogen receptor antagonist compound
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 129453-61-8
Compostos relacionados
ForteEstrutura similarSimilaridade 1.00
(8R,9S,13S,14S,17S)-13-methyl-7-(9-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonylsulfinyl)nonyl)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta(a)phenanthrene-3,17-diol
CAS2482852-42-4
n.a
SimilarEstrutura similarSimilaridade 0.77
(7alpha,17beta)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]estra-1,3,5(10)-triene-3,17-diol
CAS153004-31-0
Fulvestrant intermediate
SimilarEstrutura similarSimilaridade 0.75
Fulvestrant sulfone
CAS98008-06-1
active pharmaceutical ingredient
ReferênciaMesma categoria
Alclometasone 21-propionate
CAS129459-98-9
corticosteroid active pharmaceutical ingredient
ReferênciaMesma categoria
Milbemycin oxime
CAS129496-10-2
antiparasitic active pharmaceutical ingredient
ReferênciaMesma categoria
Glucosamine Sulfate Potassium Chloride
CAS1296149-08-0
active pharmaceutical ingredient
ReferênciaMesma categoria
Glucosamine sulfate sodium chloride
CAS1296149-13-7
active pharmaceutical ingredient
Referênciastereoisomer of
Fulvestrant, 7beta-
CAS407577-53-1
active pharmaceutical ingredient
Referência de Segurança
Perigo
H302Harmful if swallowed
H319Causes serious eye irritation
H360May damage fertility or the unborn child
H362May cause harm to breast-fed children
H373May cause damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
H413May cause long lasting harmful effects to aquatic life
Identificadores
Nome IUPAC
(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
InChIKey
VWUXBMIQPBEWFH-WCCTWKNTSA-N
SMILES
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
Sinônimos (47)
- Fulvestrant (JAN/USP/INN)
- Fulvestrant for system suitability, European Pharmacopoeia (EP)
- Fulvestrant, European Pharmacopoeia (EP)
- Fulvestrant, United States Pharmacopeia (USP)
- FULVESTRANT [MART.]
- Faslodex
- Faslodex (TN)
- Faslodex(ICI 182,780)
- Fluvestrant
- Fulvestrant
- Fulvestrant (Faslodex)
- Fulvestrant (Standard)
- Fulvestrant CRS
- Fulvestrant R enantiomer
- Fulvestrant S enantiomer
- Fulvestrant, >98% (HPLC)
- ICI 182,780
- ICI 182,780 (Fulvestrant)
- fulvestrantum